ACLIRES International Ltd. is a full-service specialty CRO with GCP-certified clinical units in Thailand and Latin America. ACLIRES primary CRO services consist of medical writing, regulatory support, project management and patient recruitment, conduct of First in Human, Phase I /II studies, site selection and site management for Phase III studies, monitoring, and clinical expert networks. ACLIRES maintains extensive patient databases providing access to special patient populations and treatment-naïve patients. ACLIRES studies and its related services are GCP-certified and fully compliant with international drug development standards and US Food and Drug Administration (FDA) and International Conference on Harmonisation (ICH) guidelines for Good Clinical Practice (GCP). The company has special expertise in infectious diseases, metabolic disorders, cardiovascular disease, oncology and CNS disorders.
Our vision is to conduct clinical trials better and more cost effectively than anyone else. We accomplish this by working with our clients to not only deliver the clinical trial effectively, on time and within budget, but also by leveraging our in-depth expertise to ensure the clinical trial is properly designed.